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Abstract
Background: The quality of dietary fats is associated with risk of cardiovascular diseases (CVD). We aimed to
investigate the association between fatty acids in erythrocyte membrane phospholipids and CVD risk factors
in middle-aged Korean adults.
Methods: Fifty-five middle-aged adults who underwent health examinations were included in this retrospective and
cross-sectional study. Anthropometry, serum lipids, clinical parameters, and erythrocyte membrane phospholipid fatty
acid data were obtained from a registry.
Results: The proportion of C14:0 and C16:0 was greatly elevated in high quartile groups for triglyceride (TG)
and systolic and diastolic blood pressure groups (SBP and DBP) (p = 0.042, p = 0.021, or p = 0.008 respectively)
compared to low quartile groups. While C16:1n7 and/or C18:1n9 were positively associated with CVD risk
factors, the delta 9 desaturase activity index (D9D) (C18:1n9/C18:0) was only significantly increased in high
quartile groups for TG and blood pressures (p = 0.001, p = 0.002 or p = 0.003). Conversely, TG and blood pressures
showed inverse relationships with C20:4n6 or D5D (C20:4n6/C20:3n6). C18:3n6 and/or D6D (C18:3n6/C18:2n6) were
positively associated with insulin resistance and diabetic parameters. Particularly high D6D was detected in high
quartile groups of FBS and insulin (p = 0.016 and p = 0.042). In linear regression analysis, D9D and/or C14:0 + C16:0 were
significant contributors to serum TG and blood pressures. D6D was a contributing factor to FBS.
Conclusions: The indices of D9D and D6D from erythrocyte membrane phospholipids and the proportion of
saturated fatty acids were increased as the cardiovascular risk factors, including serum TG, blood pressures,
and FBS increased their levels (IRB number C2014199 (1396)).
Keywords: Fatty acid composition, Erythrocyte, Cardiovascular risk, Delta 9 desaturase index, Delta 6
desaturase index
Introduction
Cardiovascular disorders (CVD) is especially prevalent
in developing countries, including Korea, due to rapid
dietary changes and Western style diets. It is well
known that the quality of dietary fats, such as satu-
rated fats, determines the risk of developing CVD [1].
For instance, dietary intake of saturated fatty acids
(SFA) was closely associated with elevated blood cho-
lesterols and increased risk of cardiovascular diseases
[2]. Dietary polyunsaturated fatty acids (PUFAs) had
an inverse relationship with the incidence of coronary
heart diseases [2]. Thus, earlier detection of changes
in dietary fat-associated CVD risk would be beneficial
for preventing CVD development.
The type of fats in diets affects the composition of
fatty acids in human bodies, including in blood [3].
Many studies have identified significant alterations at
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in the fatty acid patterns associated with CVD [4–9].
Changes in the composition of individual fatty acids
and the levels of fatty acid desaturase are frequently
assessed together to understand overall changes in
fatty acid patterns [10]. Although many studies have
tried to identify changes in fatty acid patterns in pa-
tients with CVD or associated disorders, there are
only a limited number of studies investigating the as-
sociation between fatty acids and/or fatty acid desa-
turase indices with individual risk components of
CVD [11]. Knowledge of a specific association be-
tween fatty acid indices and individual risk factors
would allow detection of alterations that could con-
tribute to CVD.
In many cases, either plasma or serum was used to in-
vestigate the composition of fatty acids relationships
with CVD [4–9]. Fatty acids in plasma or serum phospho-
lipids reflect changes in dietary intake within a few days
[12]. Erythrocyte membranes reflect long-term dietary
changes that accumulate during the life time of erythro-
cytes [13]. In this study, we aimed to investigate any sig-
nificant association between fatty acids from erythrocyte
membrane phospholipids and CVD risk factors in middle-
aged Korean men. This study was a retrospective cross-
sectional study using data from patients who underwent a
special health check-up consisting of anthropometrical
measurements, blood chemistry, and analysis of erythro-
cyte membrane phospholipid fatty acid composition.
Table 1 General characteristics of study subjects
Total Male Female Male–female
(n = 57) (n = 35) (n = 22) p-value
Age, years 52.56 ± 4.751 53.43 ± 4.231 51.18 ± 5.288 0.082
BMI, kg/m2 23.55 ± 2.624 24.47 ± 2.295 22.10 ± 2.496 0.001
SBP, mmHg 116.4 ± 16.93 120.0 ± 16.84 110.8 ± 15.87 0.046
DBP, mmHg 69.91 ± 11.68 72.17 ± 11.95 66.32 ± 10.50 0.065
TG, mg/dL 117.5 ± 61.40 131.0 ± 54.67 96.00 ± 66.51 0.035
TC, mg/dL 200.8 ± 33.97 195.3 ± 33.97 209.4 ± 32.90 0.129
HDL-C, mg/dL 53.51 ± 10.96 49.94 ± 8.691 59.18 ± 11.95 0.001
LDL-C, mg/dL 123.7 ± 30.55 119.3 ± 31.14 130.7 ± 28.90 0.171
AI 2.848 ± 0.768 2.966 ± 0.680 2.611 ± 0.857 0.142
Apo B, g/L 0.985 ± 0.186 0.998 ± 0.178 0.964 ± 0.201 0.512
FBS, mg/dl 100.7 ± 13.68 104.7 ± 14.98 94.32 ± 8.156 0.004
Insulin, μIU/ml 6.486 ± 3.833 7.178 ± 4.225 5.274 ± 2.718 0.076
HOMA-IR 1.591 ± 1.090 1.886 ± 1.183 1.122 ± 0.726 0.004
Homocysteine, μmol/L 10.44 ± 3.393 11.85 ± 3.343 8.195 ± 2.006 <0.001
HbA1c, % 5.472 ± 0.366 5.543 ± 0.414 5.359 ± 0.240 0.064
hs-CRP, mg/L 0.686 ± 0.597 0.708 ± 0.667 0.652 ± 0.477 0.736
Alcohol intake, wk 66.67 ± 61.94 98.04 ± 54.88 16.77 ± 33.24 <0.001
Total energy intake, % 98.63 ± 18.61 92.54 ± 14.10 108.3 ± 21.01 0.004
Carbohydrate intake, % 90.89 ± 34.92 88.51 ± 41.71 94.68 ± 20.25 0.521
Protein intake, % 109.2 ± 34.01 104.2 ± 32.28 117.0 ± 35.94 0.171
Fat intake, % 126.5 ± 45.45 113.0 ± 40.57 147.8 ± 45.44 0.004
Metabolic syndrome, n (%) 10 (17.54) 8 (22.86) 2 (9.091)
Central obesity, n (%) 14 (24.56) 10 (28.57) 4 (18.18)
Hypertriglyceridemia, n (%) 16 (28.07) 12 (34.29) 4 (18.18)
Low HDL-C, n (%) 12 (21.05) 7 (20.00) 5 (22.73)
Impaired fasting glucose, n (%) 10 (17.54) 9 (25.71) 1 (4.545)
Hypertension, n (%) 12 (21.05) 9 (25.71) 3 (13.64)
Postmenopausal, n (%) 10 (45.45) – 10 (45.45)
Mean ± S.D. tested by independent t test, BMI body mass index, SBP Systolic Blood Pressure, DBP Diastolic Blood Pressure, TG triglyceride, TC total cholesterol, HDL-
C high density lipoprotein cholesterol, LDL-C low density lipoprotein, cholesterol, AI (TC-HDL)/HDL, Apo B apolipoprotein B, FBS fasting blood sugar, HOMA-IR
homeostasis model assessment of insulin resistance, hs-CRP high sensitivity C-reactive protein; intake % percentage of recommended intake and the actual intake
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Results
Anthropometry, blood lipid profiles, and fatty acid
composition of erythrocyte membrane phospholipids of
study subjects
The general characteristics of study subjects (35 males
and 22 females) are shown in Table 1. Cardiovascular
risk factors used for the study included metabolic risk
factors (waist circumference, TG, HDL-C, fasting blood
glucose, systolic and diastolic blood pressures), diabetes-
related factors (insulin, HbA1c, HOMA-IR), and heart
disease-related factors (AI, hsCRP, homocysteine, ApoB).
The average values of age, systolic blood pressure (SBP),
diastolic blood pressure (DBP), total-C, LDL-C, apolipo-
protein B, insulin, hs-CRP, and HbA1c were not different
between men and women (Table 1). BMI, serum TG,
FBS, insulin, and homocysteine levels were slightly
higher in men than in women. HDL-C was higher in
women than in men (Table 1). In terms of dietary intake,
total alcohol and calorie intake were higher in men than
in women (Table 1). There were no significant differ-
ences in the percentages of fatty acids in erythrocyte
membrane phospholipids between men and women ex-
cept for linoleic acid (LA, C18:2n6) and lignoceric acid
(C24:0) (Additional file 1: Table S1). In women, LA was
slightly higher and lignoceric acid was lower compared
to men (p = 0.014 and p = 0.007, respectively) (Additional
file 1: Table S1). A total of 24.6 % of study subjects had
central obesity, 28.1 % had hypertriglyceridemia, 21.1 %
had low HDL-C, 17.5 % had impaired fasting blood glu-
cose, and 21.1 % had hypertension according to the cri-
teria for metabolic syndrome risk factors.
Correlation between erythrocyte membrane phospholipid
fatty acids and cardiovascular risk factors
The levels of cardiovascular risk factors were investi-
gated for their correlations with the proportions of fatty
acids in erythrocyte membrane phospholipids (Table 2).
The pathway of the fatty acids was shown in Fig. 1.
Among saturated fatty acids (SFA), myristic acid (C14:0)
and palmitic acid (C16:0) were positively correlated with
waist circumference, TG, SBP, DBP, FBS, insulin,
HOMA-IR, and AI and were negatively correlated with
HDL-C. Stearic acid (C18:0) showed a negative correl-
ation with TG, SBP, and DBP. Of monounsaturated fatty
acids (MUFA), palmitoleic acid (C16:1n7) and oleic acid
(C18:1n9) were positively related to TG, SBP, DBP, insu-
lin, HOMA-IR, ApoB, and homocysteine. Eicosenoic
acid (C20:1n9) and nervonic acid (C24:1n9) were nega-
tively related to TG, SBP, and DBP. Of n-6 polyunsatur-
ated fatty acids (PUFA), γ–linolenic acid (GLA,
C18:3n6) was positively correlated with TG, FBS, insulin,
AI, and HOMA-IR while arachidonic acid (AA,
C20:4n6) was negatively correlated with TG, SBP, DBP,
and apoB. Docosapentaenoic acid (C22:5n6) was
negatively related to HbA1c. The n-3 PUFAs did not
show correlation with study factors. Desaturase activity
indices including D9D, D6D, and D5D were examined
for their correlation with proportions of fatty acids. D9D
(C18:1n9 /C18:0) and D6D (C18:3n6/C18:2n6) were
positively associated with TG, SBP, DBP, FBS, insulin,
HbA1c, HOMA-IR, and apoB. D5D was negatively asso-
ciated with TG, SBP, DBP, AI, and apoB. Overall, the
findings indicated that cardiovascular risk factors were
positively associated with the percentages of C14:0 and
C16:0, C16:1n7 and C18:1n9 were associated with D9D,
and C18:3n6 and D6D were negatively associated with
C20:4n6 and D5D.
Comparison of cardiovascular risk factors in quantile
subgroups of fatty acid indices
To examine the differences in levels of cardiovascular risk
factors among the quantile subgroups of D9D, D5D, D6D,
and the sum of C14:0 and C16:0 (C14:0 + C16:0) percent-
ages, fatty acid indices were rank-transformed to generate
subgroups as quantile groups. Significant differences
among the subgroups of fatty acid indices were found in
FBS, insulin, TG, SBP, and DBP (Fig. 2a–e). As concentra-
tions of FBS and insulin increased, the D6D index values
also increased. For instance, the levels of FBS or insulin in
Q4 of D6D were significantly higher than those in Q1
(Fig. 2a, b). Serum TG levels were higher in the Q4 sub-
groups of D9D or C14:0 + C16:0 compared to Q1 of the
corresponding indices (Fig. 2c). In both SBP and DBP
quantile subgroups, the values of D9D and C14:0 + C16:0
in Q4 were higher than those of Q1 whereas the levels of
D5D in Q4 were lower than that of Q1 (Fig. 2d, e). These
results suggested that high D6D was associated with high
FBS and/or insulin, high D9D and high C14:0 + C16:0
were related to high TG, and high D9D, high C14:0 +
C16:0, and low D5D were associated with high blood
pressures.
Linear regression analysis using fatty acid indices and
CVD risk factors
The relationship between fatty acid indices and FBS, in-
sulin, TG, and blood pressures were examined after
adjusting for sex, age, and BMI (Table 3). After adjust-
ment, D6D remained significant in its association with
FBS levels but not with insulin. Regardless of the ad-
justment, D9D and C14:0 + C16:0 were significantly as-
sociated with serum TG levels. However, SBP and DBP
had altered associations with D9D, D5D, and C14:0 +
C16:0 after the adjustment. Even if the individual index
(D9D, D5D, or C14:0 + C16:0) was significant in its as-
sociation with SBP or DBP, they failed to remain signifi-
cant in a model containing all three indices.
Interestingly, adjustment increased the explanatory
powder of models for SBP or DBP and made D9D a
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Table 2 Correlation analysis between erythrocyte membrane phospholipid fatty acids and cardiovascular risk factors
BMI Waist circumference TG Apo B TC LDL-C HDL-C SBP DBP FBS Insulin AI HbA1c HOMA-IR homocysteine hs-CRP
C14:0 Myristic acid 0.283* 0.285* 0.480** 0.130 −0.053 −0.100 −0.322* 0.150 0.177 0.308* 0.429** 0.343** 0.173 0.457** 0.145 0.088
C16:0 Palmitic acid 0.256 0.279* 0.375** −0.007 −0.198 −0.299* −0.297* 0.480** 0.496** 0.146 0.129 0.122 0.000 0.209 0.033 0.139
C18:0 Stearic acid 0.043 0.059 −0.341** −0.189 −0.058 0.032 0.100 −0.326* −0.329* −0.150 −0.011 −0.205 −0.004 −0.064 −0.122 −0.038
C24:0 Lignoceric acid −0.041 0.134 −0.058 −0.075 −0.015 0.061 0.044 −0.176 −0.221 0.163 −0.085 −0.053 0.043 −0.037 0.138 −0.311*
C16:1n7, Palmitoleic acid 0.059 −0.022 0.454** 0.114 0.091 −0.079 0.023 0.140 0.209 0.228 0.098 0.078 −0.008 0.123 0.088 0.122
C18:1n9, Oleic acid 0.099 0.213 0.523** 0.345** 0.021 −0.068 −0.157 .0387** 0.407** 0.033 0.269* 0.212 0.034 0.274* 0.269* 0.110
C20:1n9, Eicosenoic acid 0.093 0.043 −0.328* −0.107 −0.156 0.022 −0.127 −0.288* −0.249 0.072 0.054 0.012 0.171 0.076 −0.184 0.115
C24:1n9, Nervonic acid −0.057 0.003 −0.227 −0.077 0.048 0.160 0.106 −0.316* −0.338* 0.098 −0.056 −0.020 0.105 −0.039 0.115 −0.201
C18:2n6 (LA) −0.214 −0.335* −0.179 0.066 0.364** 0.376** 0.216 −0.052 −0.069 −0.245 −0.109 0.013 −0.123 −0.195 −0.145 0.037
C18:3n6 (GLA) 0.125 0.090 0.359** 0.085 0.049 0.033 −0.219 0.018 0.044 0.324* 0.349** 0.265* 0.250 0.286* 0.029 0.041
C20:2n6 (EDA) −0.136 −0.140 −0.092 0.051 0.104 0.005 0.283* −0.096 −0.087 −0.113 −0.056 −0.248 0.055 −0.038 0.079 −0.042
C20:3n6 (DGLA) 0.168 0.080 0.065 0.127 0.095 0.149 −0.160 0.212 0.241 0.046 0.163 0.181 0.209 0.137 0.127 0.245
C20:4n6 (AA) −0.080 −0.020 −0.469** −0.284* −0.159 0.012 0.004 −0.284* −0.276* −0.034 −0.188 −0.201 0.108 −0.220 −0.051 0.005
C22:4n6 (DTA) 0.165 0.147 −0.244 −0.147 −0.084 0.065 −0.140 −0.027 −0.011 0.145 0.165 −0.037 0.131 0.130 0.003 0.064
C22:5n6 (DPA) −0.178 −0.104 0.128 0.199 0.287* 0.245 0.166 −0.032 −0.090 −0.174 −0.165 −0.001 −0.265* −0.224 0.048 −0.006
C18:3n3 (ALNA) 0.024 −0.057 0.215 0.011 −0.029 −0.081 −0.048 0.085 0.050 0.043 0.087 0.060 −0.168 −0.012 −0.162 0.123
C20:5n3 (EPA) 0.181 0.202 −0.166 −0.113 −0.221 −0.237 −0.041 0.017 0.032 0.138 −0.035 −0.053 0.063 0.055 0.063 −0.150
C22:5n3 (DPA) 0.182 0.229 −0.185 −0.224 −0.316* −0.247 −0.151 −0.091 −0.090 0.185 −0.005 −0.096 0.048 0.072 −0.093 −0.108
C22:6n3 (DHA) 0.874 0.075 0.039 −0.117 −0.143 −0.227 −0.107 0.044 0.036 0.114 −0.147 0.008 0.011 −0.082 –.0810 –.0582
D5D −0.233 −0.126 −0.035** −0.291* −0.179 −0.117 0.158 −0.366** −0.400** −0.056 −0.248 −0.302* −0.155 −0.240 −0.179 −0.228
D6D 0.191 0.191 0.365** 0.048 −0.070 −0.078 −0.284* 0.003 0.049 0.383** 0.364** 0.089 0.303* 0.330* 0.087 0.044
D9D 0.042 0.119 0.546** 0.318* 0.016 −0.097 −0.167 0.453** 0.459** 0.060 0.179 0.226 −0.020 0.196 0.236 0.127
Mean ± S.D.; Significantly correlated by pearson correlation analysis at *p <0.05, and **p <0.01 and respectively
AA Arachidonic acid, ALNA α-Linolenic acid, DGLA Dihomo-γ-linolenic acid, DHA Docosahexanoic acid, DPA Docosapentaenoic acid, DTA Docosatetraenoic acid, D5D delta-5-Desatuase (C20:4 ω-6/C20:3 ω-6), D6D delta-
6-Desatuase(C18:3 ω-6/C18:2 ω-6), D9D delta-9-Desatuase(C18:1 ω-9/C18:0), EDA Eicosadienoic acid, EPA Eicosapentaenoic acid, GLA γ-linolenic acid, LA Linoleic acid, MUFA monosaturated fatty acid, PUFA polysaturated
fatty acid, SFA saturated fatty acid, C22:5 ω-6(Docosapentaenoic acid, DPA) = osbond acid; C22:5 ω-3 (Docosapentaenoic acid, DPA) = clupanodonic acid, BMI body mass index, SBP Systolic Blood Pressure, DBP Diastolic
Blood Pressure, TG Triglyceride, TC total cholesterol, HDL-C high density lipoprotein cholesterol, LDL-C low density lipoprotein, cholesterol, AI (TC-HDL)/HDL, Apo B apolipoprotein B, FBS fasting blood sugar, HOMA-IR















significant contributor to SBP or DBP. These data sug-
gested that D6D, D9D, and D9D and C14:0 + C16:0
demonstrated strong associations with FBS, blood pres-
sures, and TG, respectively, after adjusting for sex, age,
and BMI.
Correlation between frequency of dietary intake of food
groups and fatty acids in erythrocyte membrane
phospholipids
There was a positive association between C16:1n7 and
the vegetable and seaweed group (r = 0.437, p = 0.001).




Fig. 2 Comparison of cardiovascular risk factor levels in quartile subgroups of fatty acid indices. (a) fasting blood glucose (FBS) levels in the quartile
groups of delta 6 desaturase index (D6D), (b) fasting insulin levels in the quartile groups of D6D index, (c) triglyceride (TG) levels in the quartile groups
of delta 9 desaturase (D9D) index and the sum of C14:0 and C16:0 (C14C16), (d) systolic blood pressure (SBP) levels in the quartile groups of D9D, delta
5 desaturase index (D5D) and C14C16, and (e) diastolic blood pressure (DBP) levels in the quartile groups of D9D, D5D and C14C16
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Dairy product intake showed a negative association with
C20:3n6 and C22:4n6 (r = −0.333, p = 0.011 and r =
−0.306, p = 0.020). The food group for tofu and eggs was
positively associated with C20:5n3 (r = 0.314, p = 0.017).
Other food groups, including meat, fish, shellfish, fruit,
and rice, did not show any significant associations in the
study subjects.
Discussion
The study subjects were middle-aged men and women
who were mostly over 50 years old, lived in the metro-
politan area of South Korea, and were able to afford a
special health check-up. The fatty acid patterns in the
RBC membrane phospholipids in these subjects were in-
vestigated for their relationships with cardiovascular
risk-associated parameters. After confirming the correl-
ation between several individual fatty acids with cardio-
vascular risk-related factors, fatty acid indices were
utilized to further investigate the relationships, including
D6D, D5D, D9D, and C14:0 + C16:0. The current study
was a retrospective clinical study and only a mini dietary
assessment index for nutritional dietary intake analysis
was available. The total energy, carbohydrate and protein
intake, and alcohol consumption were estimated. Esti-
mated alcohol consumption was adjusted for an analysis
of the association of fatty acid indices with cardiovascu-
lar risk factors. In study subjects, the proportions of
C20:5n3, C22:5n3, and C22:6n3 had no significant asso-
ciation with levels of cardiovascular risk factors.
C20:5n3, C22:5n3, and C22:6n3 are long chain fatty
acids (LCFAs) often used as markers of fish intake [14].
Based on the criteria for metabolic syndrome, 24.6 % of
study subjects were centrally obese, and 22.4 % were obese
according to BMI criteria (reference). BMI showed a posi-
tive association with C14:0. Waist circumference, another
marker for abdominal obesity, was positively associated
with C14:0 and C16:0 but negatively correlated with
C18:2n6. These findings might indicate high dietary intake
of SFAs and low intake of C18:2n6 in the subjects because
C18:2n6 is not produced in the body. These results are
similar to previous findings suggesting a positive associ-
ation of obesity-related markers (BMI and waist circum-
ference) with SFAs such as C16:0 and a negative
association with C18:2n6 [11]. Therefore, lower dietary in-
take of C18:2n6 might be associated with increased BMI.
In another study, sagittal abdominal diameter and waist
girth were used as obesity-related markers. These markers
showed strong positive association with D9D for C16:0
and D6D and a negative association with D5D [11]. This
difference could be due to the relatively small number of
subjects used in our study, which might have missed small
changes in fatty acid patterns.
Alterations in serum lipid profiles are known risk fac-
tors for CVD. Of study subjects, 27 % had hypertriglyc-
eridemia and 21 % had low HDL-C. AI and serum TG
levels showed a positive relation with SFAs C14:0 and
C16:0 whereas HDL-C was negatively associated with
these markers. High saturated and/or animal fat diets in-
crease serum TG levels [15]. Because palmitate (C16:0)
is the most abundant SFA, the proportion of SFAs is
likely to reflect that of C16:0. The sum of the propor-
tions of C14:0 and C16:0 (C14:0 + C16:0) were used to
further analyze its association with risk factors. The
highest quartile groups of C14:0 + C16:0 showed signifi-
cantly higher serum TG. C14:0 + C16:0 was a significant
contributor to serum TG in linear regression analysis.
Our findings support previous suggestions of a positive
association between SFA and CVD.
We also noticed that serum TG had strong positive as-
sociations with C16:1n7 and C18:1n9. D9D catalyzes the
production of C16:1n7 and C18:1n9 from C16:0 and
C18:0, respectively [16]. The ratio of C18:1n9 to C18:0
was used to estimate D9D activity in this study. For
serum TG and blood pressures, the highest quartile of
D9D showed significant elevations in TG and blood
pressures. In a linear regression analysis, D9D was a sig-
nificant contributor to serum TG and blood pressures.
Table 3 Linear regression analysis with fatty acid indices and its
associated risk factors
R2 adjR2 B S.E. P
FBS D6D .150 .135 31.28 10.04 .003
adj D6D .278 .223 25.59 9.702 .011
Insulin D6D .082 .065 6.403 2.942 .034
adj D6D .172 .105 5.062 2.946 .092
TG D9D 0.454 0.433 439.5 101.09 .000
C14C16 23.76 5.561 .000
adj D9D 0.518 0.471 496.7 102.4 .000
adj C14C16 17.79 5.876 .004
SBP D9D 0.211 0.166 54.88 34.27 .115
D5D −31.91 22.81 .168
C14C16 3.720 2.025 .072
adj D9D 0.355 0.277 77.61 33.46 .024
adj D5D −27.29 21.30 .206
adj C14C16 1.560 2.025 .445
DBP D9D 0.235 0.192 39.68 23.25 .094
D5D −22.56 15.47 .151
C14C16 2.785 1.374 .048
adj D9D 0.329 0.248 51.95 23.52 .032
adj D5D −20.01 14.97 .187
adj C14C16 1.585 1.424 .271
Tested by linear regression; adj adjusted after age, BMI body mass index and sex;
FBS fasting blood sugar, TG Triglyceride, SBP Systolic Blood Pressure, DBP Diastolic
Blood Pressure, D5D delta-5-Desatuase (C20:4 ω-6/C20:3 ω-6), D6D delta-6-
Desatuase (C18:3 ω-6/C18:2 ω-6), D9D delta-9-Desatuase (C18:1 ω-9/C18:0; C14C16
the sum of C14:0 (myristic acid) + C16:0 (palmitic acid)
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The physiological role of D9D on regulation of adiposity,
insulin resistance, and lipid synthesis has been impli-
cated in an animal model [17]. Overexpression of D9D,
which is usually referred to as stearoyl CoA desaturase-1
(SCD-1), showed an increase in TG production. A genet-
ically modified mouse model lacking SCD-1 displayed
significant reduction in serum TG [17, 18]. Based on
these observations, the increase in D9D might reflect el-
evated production of TG in our study subjects. In our
analysis of food groups, C16:1n7 was positively corre-
lated with dietary intake of vegetables and seaweeds.
This was unexpected considering the positive association
between C16:1n7 and serum TG. These results warrant
a further large scale study with detailed dietary intake to
verify.
Other cardiovascular risk factors, including ApoB,
blood pressures, HOMA-IR, and homocysteine, were
also positively correlated with C18:1n9. Inconsistent with
our findings, an increased incidence of left ventricular
hypertrophy and cardiovascular risk factors were shown
to be strongly associated with increased SFA and
C18:1n9 in serum cholesterol esters [19].
Interestingly, high blood pressures are significantly as-
sociated with high D9D and low C24:1n9. Changes in
D9D were closely associated with blood TG, which
might indirectly influence blood pressures. C24:1n9
levels in erythrocyte membrane fatty acids were highly
positively associated with dietary PUFA intake along
with C18:3n3 and C18:2n6 [20]. Inverse relations be-
tween C24:1n9 and blood pressures suggests that low
dietary PUFA intake in our subjects was related to high
blood pressures.
C18:1n9 was positively associated with both serum TG
and blood pressures, but C20:1n9 and C24:1n9 had
negative associations with these risk factors. These find-
ings suggest that monounsaturation in long chain fatty
acids with fewer than 20 carbon atoms (<20 carbon-
LCFAs) was likely associated with high TG and high
blood pressure while monounsaturation in >20 carbon-
LCFAs was inversely related to serum TG and blood
pressures.
C20:4n6 and C20:5n3 are produced by series action of
D6D, elongase and D5D [21, 22]. A high ratio of
C20:4n6 to C20:5n3 (AA/EPA ratio) is related to the risk
of cardiovascular disorders [23]. C20:4n6 is a substrate
for the enzymes for the production of pro-inflammatory
cytokines and C20:5n3 competes with C20:4n6 [23]. On
the other hand, a low ratio of C20:4n6 to C20:3n6 was
previously detected prior to the development of myocar-
dial infarctions in middle-aged men [8], suggesting that
low D5D (C20:4n6/C20:3n6) might be related to CVD
risk factors. In our study, D5D showed a negative associ-
ation with serum TG, blood pressure, ApoB, and AI.
Low C20:4n6 was related to high levels of serum TG,
blood pressures, and ApoB. However, only blood pres-
sure levels were significantly different for D5D quartile
groups. In univariate linear regression, D5D was a sig-
nificant contributor to blood pressure but did not re-
main significant with multivariate linear regression
analysis. This suggests that the association of D5D with
blood pressures did not attain statistical significance
after the adjustment of BMI, age and sex. Instead, D9D
appeared to be statistically associated with blood pres-
sure in that analysis. The high content of C22:6n3 (doco-
sahexaenoic acid, DHA) was shown to exert
cardiovascular protective effects [24]. However in our
study we didn’t see a statistical association with clinical
parameters related to cardiovascular disorders. Our data
may provide evidence to support that high D9D is asso-
ciated with elevated blood pressures.
Diabetes-associated risk factors, including FBS, insu-
lin, and HOMA-IR were strongly associated with
C14:0 and C18:3n6, a product generated by D6D.
D6D also showed positive correlations with FBS,
HbA1c, and HOMA-IR. The highest quartile of D6D
had the highest levels of FBS. In linear regression
analysis, adjusted D6D remained significant for FBS,
indicating that D6D might contribute to FBS. Our
findings are in line with previous reports showing
that insulin resistance was associated with an increase
in D6D and C18:3n6 [25, 26]. In a 10 year follow-up
study, subjects who developed non-insulin-dependent
diabetes mellitus (NIDDM) had high SFA and
C18:3n6 [26]. Apart from D6D, low C18:2n6 has been
implicated in insulin resistance and metabolic syn-
drome [27]. Other studies have reported that im-
paired fasting glycemia and diabetes were associated
with high SFA and low C18:2n6 [28]. High D9D has
been implicated in insulin resistance and diabetic
conditions [27, 29]. Insulin sensitivity was improved
in an animal model with deficient D9D [17]. These
findings indicate that low D6D, low D9D, and high
C18:2n6 are associated with decreased risk of diabetes
and associated conditions.
Conclusions
Here, we provided evidence that the fatty acid pat-
terns of erythrocyte membrane phospholipids are
strongly associated with CVD risk factors in middle
aged Koreans. In particular, high serum TG is associ-
ated with high D9D and C14:0 + C16:0. FBS was posi-
tively associated with D6D. SBP and DBP showed
strong positive associations with D9D. Because our
study was a retrospective cross-sectional study, we
could not infer the cause and effect relationship be-
tween fatty acid indices and CVD risk factors. Specific
associations found in our study warrant further large
scale studies involving a greater number of subjects.
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Methods and materials
Subjects
All the data from patients were retrieved from a registry
upon approval by Chung-Ang University Institutional
Review Board (IRB) (IRB number C2014199 (1396)). Pa-
tients who underwent a specialized health examination
from January 2014 until January 2015 at Chung-Ang
University Hospital Examination Centre were initially
assessed for eligibility. Inclusion criteria were age be-
tween 40 years and 65 years, anthropometry measure-
ments, blood biochemistry, erythrocyte membrane fatty
acid composition, and dietary intake assessment. From
62 participants in total, five patients were excluded due
to missing measurement data. Chung-Ang University
IRB approved all procedures for this research.
Anthropometric measurements
A body composition analyzer (Inbody720®, Biospace,
Korea) was used to measure height (cm), weight (kg),
body fat percentage (%), and waist circumference
(cm). Body mass index (BMI) was measured using the
obtained height and weight. Blood pressure was mea-
sured from the arms using an automatic blood pres-
sure monitor (HEM – 1000, OMRON, Japan) after
patients had rested for 10 minutes and a steady heart
rate was achieved. The values were averaged from
two readings of systolic and diastolic blood pressures.
Biochemical analysis
Blood tests were carried out after 10 hours of fasting.
Three ml of blood obtained from the forearm vein
(cephalic vein, basilica vein) was collected in a vac-
uum blood collection bottle. Blood was treated with
3 % EDTA and centrifuged at 4 °C, 3000 rpm for
15 minutes to separate the plasma. Separated plasma
was stored at −20 °C until analysis. Blood levels of
fasting blood glucose (FBS), HbA1c, total cholesterol
(Total-C), HDL cholesterol (HDL-C), LDL cholesterol
(LDL-C), triglycerides (TG), aspartate aminotransfer-
ase (AST), alanine aminotransferase (ALT), homocyst-
eine, and apolipoprotein B (ApoB) were assessed
using an automatic chemistry analyzer (ADI-VA 1650
Chemistry System, Bayer, Tarrytown, NY, USA).
Hypersensitive C reactive peptide (hs-CRP) was mea-
sured using COBAS INTEGRA 700 (Roche Diagnostic
System, Basel, Switzerland) with the particle enhanced
immunoturbidometric method. Artherogenic index
(AI) was calculated using the formula ‘(Total-C-HDL-
C)/HDL-C’ [30]. Insulin resistance was calculated
using the formula ‘fasting insulin (U/ml) x fasting
plasma glucose (mmol/L) / 22.5’ based on the homeo-
stasis model assessment (HOMA) method [31].
Red blood cell membrane fatty acid analysis
After centrifugation of blood in an EDTA-treated tube
at 4 °C, 3000 rpm for 15 minutes, red blood cells were
separated from plasma. Red blood cells were washed
three times using phosphate buffered saline (PBS
pH7.2). The total volume of red blood cells was doubled
by adding PBS to the RBC suspension, and then samples
were stored frozen at −20 °C until analysis. As an in-
ternal standard to measure lipid weight, 100 μg of hepta-
decanoic acid (17:0) was added to 200 ml of plasma. The
extraction of total lipids from RBC and plasma was car-
ried out using ice-cold chloroform/methanol (2:1, v/v)
containing 0.01 % (w/v) butylated hydroxytoluene (BHT)
by the Folch method [32]. The Lepage and Rog method
was used to generate methyl ester forms of fatty acids
[33]. Prior to lipid extraction from RBCs, the RBCs were
saponified and non-saponified fats were removed using
the modified method generated by Tilvis and Miettinen
[34]. Lipid extraction from saponified RBCs was carried
out by the same method described for plasma. Fatty acid
methyl esters were separated and analyzed by Shimadzu
GC-9A gas chromatography (Shimadzu Corp., Kyoto,
Japan) equipped with a flame ionization detector and a
fused silica capillary column (FS-WCOT, 30 m ×
0.2248 mm id 0.15 μm film thickness). The injector and
detector temperature was 270 °C. Helium gas was used
as a carrier gas at a flow rate of 25 ml/min and split ra-
tio of 1:100. Fatty acid methyl esters were identified by
comparing their retention times with those of standards
purchased from Sigma. The activities of delta 5 desatur-
ase (D5D), delta 6 desturase (D6D), and delta 9 desatur-
ase (D9D) were estimated using the ratios of C20:4n-6
and C20:3n-6 for D5D activity, C18:3n-6 and C18:2n-6
for D6D activity, and C18:1 and C18:0 for D9D activity
[25, 35]. Total SFA was the sum of the percentage of
C14:0, C16:0, C18:0, and C24:0. Total MUFA was the
sum of C16:1n7, C18:1n9, C20:1n9, and C24:1n9. Total
PUFA was the sum of C18:2n6, C18:3n6, C20:2n6,
C20:3n6, C20:4n6, C22:4n6, C22:5n6, C18:3n6, C20:5n3,
and C22:5n3.
Dietary intake questionnaire
To assess diet quality, a modified version of the mini
dietary assessment index for Korean adults (K-MDA) de-
veloped by Kim et al. [36] was used. The questionnaire
consisted of 10 questions from K-MDA and an add-
itional 10 questions. Each question is shown in Table 1.
The 20 questions were assessed using a 5-point Likert
scale (1: Never, 3: Sometimes, 5: Always) with a total of
100 points. Five points refers to desirable eating habits,
while 3 points and 1 point refer to normal eating habits
and unhealthy eating habits that require improvement,
respectively. For questions 1–7, 13,16, and 18–20, an-
swers were worth ‘Always’ - 5 points, ‘Sometimes’ – 3
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points, and ‘Never’ – 1 point. For questions 8, 14, 15, 16,
and 17, each answer was worth ‘Always’ - 1 point, ‘Some-
times’ – 3 points, and ‘Never’ – 5 points. The total score
was then calculated. Higher total scores indicate health-
ier eating habits.
Statistical analysis
All data were statistically analyzed using SPSS Version
21.0 (SPSS Inc., Chicago, IL, USA). The values were
expressed as mean and standard deviation (SD). To
compare men and women, the study variables were ex-
amined by independent t-test if variables demonstrated
normal distribution or by Mann–Whitney U test if vari-
ables were not normally distributed. Normal distribution
was assessed by the Shapiro-Wilk test. Relationships
among BMI, blood pressures, blood chemistry, and pro-
portions of fatty acids were tested using Spearman’s rank
correlations. To evaluate the relationships between fatty
acid indices and cardiovascular risk factors, D9D, D5D,
D6D, and C14:0 + C16:0 values were rank-transformed
and classified into categorical variables: Q1 (below 25 %
quantile), Q2 (between 25 and 50 %), Q3 (between 50
and 75 %), and Q4 (above 75 % quantile). Differences in
the values of cardiovascular risk factors among categor-
ical groups were evaluated using a nonparametric
Kruskal-Wallis test followed by a nonparametric two-
tailed Mann–Whitney test. Univariate relationships be-
tween cardiovascular risk factors and fatty acid indices,
including D9D, D5D, D6D, M/S ratio, and C14:0 + C16:0
were tested using simple linear regression analysis ad-
justed for sex, age, and BMI. In these analyses, D9D,
D5D, and D6D were logarithmically transformed. A
value of p <0.05 was considered statistically significant.
Additional file
Additional file 1: Table S1. Fatty acid compositions in the male and
female subjects in the study. (DOCX 16 kb)
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